Protein Assay Market, by Product Type (Reagents and Kits (Dye Binding Assays, Copper-Ion based Assays, Test Strip based Assays, Other Protein Assays) and Instruments) by Technology Type (Absorbance based Protein Assays, Colorimetric Protein Assays, Fluor

Protein Assay Market, by Product Type (Reagents and Kits (Dye Binding Assays, Copper-Ion based Assays, Test Strip based Assays, Other Protein Assays) and Instruments) by Technology Type (Absorbance based Protein Assays, Colorimetric Protein Assays, Fluorescence based Protein Assays),by End User (Pharmaceutical and Biotechnology Industry, Clinical Laboratories, Hospitals, Academic Research Institutes) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Protein assays are useful for detailed mechanistic studies of a target protein, bioanalytical measurements, and high-throughput screening. Assays have diverse applications such as analysis of enzyme activities, nucleic acid-protein interactions, protein-protein interactions, and small molecule binding to proteins. Depending on the accuracy required and the amount and purity of the protein available, different methods are appropriate for determining protein concentration. The different methods for determination of protein concentration namely Kjeldahl Method, biuret method, bicinchoninic acid (BCA) assay, Folin-Ciocalteu (Lowry) Assay, Dye-Binding (Bradford) Assay. Among all the methods of protein concentration determination Bicinchoninic acid Assay BCA assay is one of the most sensitive method.

Market Dynamics

Initiatives such as study of genomics and proteomics in biotechnology and pharmaceutical industries is expected to fuel growth of the protein assay market. For instance, according to the data published in July 2017 issue of Neurology Genetics, an official journal of the American Academy of Neurology, researchers at New York Genome Center had reported strong potential of International Business Machines Corporation (IBM) Watson for genomics that analyzes complex genomic data to help clinicians with precision medicine. Diagnostic and prognostic assays aid in early diagnosis of diseases such as chronic disease thus, helping in offering right treatment for chronic disease. This is expected to drive growth of the protein assay market. Furthermore, continuous collaboration among protein assays manufacturers for various applications such as quantification, detection in clinical and translational research is also expected to lead to rapid growth of market over the forecast period. For instance, in August 2017, Abcam and Thrombotic Thrombocytopenic Purpura (TTP) Labtech entered into a collaboration to develop reagent kits for quantification of secreted proteins in multiplexed screening assays, which enable to deliver data driven faster.

Key features of the study:

• This report provides an in-depth analysis of the global protein assay market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global protein assay market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., GE Healthcare, Merck KGaA, Bio-Rad Laboratories, Inc., Lonza, Abcam plc, PerkinElmer Inc., Bio-Techne, BioVision Inc., Cell Signaling Technology, Inc., and Geno Technology Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global protein assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global protein assay market

Detailed Segmentation:

• Global Protein Assay Market, By Product Type:
• Reagents and Kits
• Dye Binding Assays
• Copper-Ion based Assays
• Test Strip based Assays
• Other Protein Assays
• Instruments
• Global Protein Assay Market, By Technology Type :
• Absorbance based Protein Assays
• Colorimetric Protein Assays
• Fluorescence based Protein Assays
• Global Protein Assay Market, By End User :
• Pharmaceutical and Biotechnology Industries
• Clinical Laboratories
• Hospitals
• Academic Research Institutes
• Global Protein Assay Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Thermo Fisher Scientific Inc.*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Bio-Rad Laboratories, Inc.
• Merck KGaA
• Ardelyx PerkinElmer Inc.
• Abcam plc.
• Cell Signaling Technology, Inc.
• GSK plc. Bio-Techne
• BioVision Inc.
• Geno Technology Inc.
• Lonza

“*” marked represents similar segmentation in other categories in the respective section.